Open AccessEfficacy and safety of Glycebal (PDM011011) capsules as adjuvant therapy in subjects with type 2 diabetes mellitus: an open label, randomized, active controlled, phase II trial
Author(s) -
Ashish Suthar,
Anand Deshmukh,
V. R. R. M. Babu,
Vijaya Mohan,
Madhukar V. Chavan,
Dutta Kumar,
Vijaysingh Chauhan,
Somesh Sharma,
Mahesh Sharma
Publication year - 2016
Publication title -
clinical diabetology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.152
H-Index - 4
eISSN - 2450-8187
pISSN - 2450-7458
DOI - 10.5603/dk.2016.0015
Subject(s) - medicine , placebo , adverse effect , capsule , diabetes mellitus , population , gastroenterology , randomized controlled trial , adjuvant therapy , surgery , chemotherapy , endocrinology , pathology , botany , alternative medicine , environmental health , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom